The document is an update to a 1997 guidance document and intends to clarify when device manufacturers should submit pre-market notification for an update or modification to device that has already been approved by the FDA.
Related Articles on the FDA:
FDA Launches Website on Safe Disposal of Used Needles and Other “Sharps”
FDA Approves Anti-Clotting Drug Xarelto
FDA Reports Increase in New Drug Approvals in FY 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.